Many are also forgetting an impressive Phase 2 ovarian cancer trial and veterinary applications already utilized
I am forgetting, that is true.
What I remember is that UofPen ran a P1 with DCVax in ovarian. They were so unimpressed that they withdrew the planned P2 and instead used a very different DC technology in future trials.